DRG Market Assessment reports

Clarivate Epidemiology’s coverage of osteopenia (OPE) comprises epidemiological estimates of key patient populations in seven emerging pharmaceutical markets. We report the prevalence of OPE for…

Clarivate Epidemiology’s coverage of osteopenia (OPE) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany…

Clarivate’s Epidemiology’s coverage of osteopenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of osteopenia for each…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key OPE patient populations, covering 171 countries and more than 99% of…

Clarivate Epidemiology’s coverage of marginal zone lymphoma (MZL) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…

Clarivate Epidemiology’s coverage of progressive supranuclear palsy (PSP) comprises epidemiological estimates of diagnosed prevalence in the major mature pharmaceutical markets of the United…

Clarivate Epidemiology’s coverage of cervical cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key cervical cancer patient populations, covering 171 countries and more…

Clarivate Epidemiology’s coverage of cervical cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and diagnosed…

Clarivate Epidemiology’s coverage of hepatocellular carcinoma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence…

Clarivate Epidemiology’s coverage of osteoarthritis (OA) pain comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France…

Clarivate Epidemiology’s coverage of Rett syndrome comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…